Emmanuelle Charpentier and Jennifer Doudna
Nobel Media. Ill. Niklas Elmehed.
Emmanuelle Charpentier at the Max Planck Institute for Infection Biology in Germany and Jennifer Doudna at the University of California, Berkeley, have won this year’s Nobel prize in chemistry for pioneering the genome editing tool CRISPR-Cas9. The pair were recognised for their work on the widely used technique, which has applications for new medicines, crops and more.
“This is a technology method that can provide humankind with great opportunities,” said Claes Gustafsson of the Nobel Committee for Chemistry, speaking as the prize was announced today at the Royal Swedish Academy …
You may also like
New Bariatric Portion Plate Helps Bariatric Patients Reach Their Goals
2021 preview: how soon will a Covid-19 vaccine normalize life?
Official British statisticians had concerns about the trend in the Covid-19 poll
NASA’s probe on Mars may feel the ground shake when rovers land in 2021
International Study Shows This Brain Supplement Reverses Years of Mental Decline and May Also Reduce the Risk of Dementia